Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma, Kaposi × Zidovudine × Clear all

Phase

Phase 1 6 Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1 AIDS-Related Opportunistic Infections 1

Interventions

Doxorubicin 5 Liposomes 4 Vincristine 3 Bleomycin 3 liposomal doxorubicin 1 Zidovudine 1 Paclitaxel 1 Etoposide 1 Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 Daunorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00000994 2021-11-04

A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡